BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 28427222)

  • 1. Prognostic role of matrix metalloproteinases in bladder carcinoma: a systematic review and meta-analysis.
    Miao C; Liang C; Zhu J; Xu A; Zhao K; Hua Y; Zhang J; Chen W; Suo C; Zhang C; Liu Y; Su S; Wang Z
    Oncotarget; 2017 May; 8(19):32309-32321. PubMed ID: 28427222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
    Luo Y; Zhang X; Mo M; Tan Z; Huang L; Zhou H; Wang C; Wei F; Qiu X; He R; Chen G
    Medicine (Baltimore); 2016 Apr; 95(15):e3337. PubMed ID: 27082587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Role of Matrix Metalloproteinases in Cervical Cancer: A Meta-Analysis.
    Chen W; Huang S; Shi K; Yi L; Liu Y; Liu W
    Cancer Control; 2021; 28():10732748211033743. PubMed ID: 34482737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of MMPs Functions as a Prognostic Biomarker for Oral Cancer Patients: A Systematic Review and Meta-analysis.
    Deng W; Peng W; Wang T; Chen J; Zhu S
    Oral Health Prev Dent; 2019; 17(6):505-514. PubMed ID: 31825023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of lymphovascular invasion in bladder cancer after surgical resection: A meta-analysis.
    Tian YF; Zhou H; Yu G; Wang J; Li H; Xia D; Xiao HB; Liu JH; Ye ZQ; Xu H; Zhuang QY
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):646-655. PubMed ID: 26489616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis.
    Sun S; Dong H; Yan T; Li J; Liu B; Shao P; Li J; Liang C
    BMC Med Genet; 2020 Jun; 21(1):139. PubMed ID: 32600280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta-analysis.
    Zhang P; Hu P; Shen H; Yu J; Liu Q; Du J
    Eur J Clin Invest; 2014 Nov; 44(11):1072-94. PubMed ID: 25257753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of tissue vascular endothelial growth factor expression in bladder cancer: a meta-analysis.
    Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
    Asian Pac J Cancer Prev; 2013; 14(2):645-9. PubMed ID: 23621212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis.
    Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Jiang Y
    World J Urol; 2020 Jan; 38(1):129-142. PubMed ID: 30919100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-Analysis.
    Gan X; Lin X; He R; Lin X; Wang H; Yan L; Zhou H; Qin H; Chen G
    Dis Markers; 2016; 2016():5259602. PubMed ID: 27199504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
    Qi F; Xu Y; Zheng Y; Li X; Gao Y
    Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvessel density as a prognostic factor in bladder cancer: a systematic review of literature and meta-analysis.
    Huang J; Ma X; Chen X; Liu X; Zhang B; Minmin L; Nie W; Zhang L; Liu L
    Cancer Biomark; 2014; 14(6):505-14. PubMed ID: 25335742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs in bladder cancer prognosis: A meta-analysis.
    Zhu W; Liu H; Wang X; Lu J; Yang W
    Pathol Res Pract; 2019 Jun; 215(6):152429. PubMed ID: 31064722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis.
    Xie Y; Ma X; Chen L; Li H; Gu L; Gao Y; Zhang Y; Li X; Fan Y; Chen J; Zhang X
    Sci Rep; 2017 Jul; 7(1):5619. PubMed ID: 28717125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis.
    Wen Y; Chen Y; Duan X; Zhu W; Cai C; Deng T; Zeng G
    Clin Exp Med; 2019 Nov; 19(4):407-416. PubMed ID: 31407099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of microRNA-148/152 family as a prognostic factor in multiple human malignancies: a meta-analysis.
    Miao C; Zhang J; Zhao K; Liang C; Xu A; Zhu J; Wang Y; Hua Y; Tian Y; Liu S; Zhang C; Qin C; Wang Z
    Oncotarget; 2017 Jun; 8(26):43344-43355. PubMed ID: 28574848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis.
    Jiang H; Gu X; Zuo Z; Tian G; Liu J
    PLoS One; 2021; 16(7):e0254433. PubMed ID: 34242363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review.
    Wu T; Zhang W; Yang G; Li H; Chen Q; Song R; Zhao L
    Oncotarget; 2016 Aug; 7(31):50417-50427. PubMed ID: 27391431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.